Interact to see
Advertisement
Advertisement
ESFIX vs MEDAX
ESFIX vs MEDAX Comparison
Open Charts ESFIX vs MEDAX
Ashmore Emerging Markets Short Dur Instl
Price$4.86
Change-$0.01 (-0.21%)
VolumeN/A
Net Assets31.23M
MFS Emerging Markets Debt A
Price$12.54
Change-$0.02 (-0.16%)
VolumeN/A
Net Assets7.57B
ESFIX vs MEDAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ESFIX vs. MEDAX commentary
Oct 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESFIX is a Hold and MEDAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDAX has more cash in the bank: 7.57B vs. ESFIX (31.2M). MEDAX pays higher dividends than ESFIX: MEDAX (5.26) vs ESFIX (3.75). ESFIX was incepted earlier than MEDAX: ESFIX (11 years) vs MEDAX (28 years). ESFIX (1.37) is less costly to investors than MEDAX (1.07). MEDAX has a lower initial minimum investment than ESFIX: MEDAX (1000) vs ESFIX (1000000). MEDAX annual gain was more profitable for investors over the last year : 8.25 vs. ESFIX (4.96). MEDAX return over 5 years is better than : 11.82 vs. ESFIX (-7.39).
| ESFIX | MEDAX | ESFIX / MEDAX | |
| Total Expense Ratio | 0.88 | 1.06 | 83% |
| Annual Report Gross Expense Ratio | 1.37 | 1.07 | 128% |
| Fund Existence | 11 years | 28 years | - |
| Gain YTD | 5.626 | 9.171 | 61% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 31.2M | 7.57B | 0% |
| Annual Yield % from dividends | 3.75 | 5.26 | 71% |
| Returns for 1 year | 4.96 | 8.25 | 60% |
| Returns for 3 years | 40.67 | 41.73 | 97% |
| Returns for 5 years | -7.39 | 11.82 | -63% |
| Returns for 10 years | 8.16 | 44.83 | 18% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers